Legal Representation
Attorney
David A. Bell
USPTO Deadlines
Next Deadline
172 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
April 29, 2026
Extension Available
Until October 29, 2025
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 24, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 24, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 14, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Aug 14, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 14, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 14, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 22, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 22, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 21, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 21, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 3, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jan 3, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 3, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 3, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 29, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 31, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 31, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 31, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 31, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jul 31, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 2, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 1, 2024 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 1, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 5, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals used for the treatment and prevention of diseases, disorders and conditions of the pulmonary system, and for the treatment and prevention of exacerbations of these diseases, disorders and conditions; pharmaceuticals used for the treatment and prevention of infections; pharmaceuticals used for the treatment and prevention of headaches and neurological conditions; drug delivery agents comprising formulations that facilitate delivery of a wide range of pharmaceuticals to the pulmonary system; drug delivery agents comprising formulations that facilitate systemic delivery of a wide range of pharmaceuticals by way of the pulmonary system
Additional Information
Design Mark
The mark consists of the wording "ISPERSE" in stylized font, of which "I" appears in light blue, "SPERSE" in blue, and the tittle of "I" in turquoise color. This wording has an underline in blue and light blue colors.
Color Claim
The color(s) blue, light blue, and turquoise is/are claimed as a feature of the mark.
Pseudo Mark
I SPERSE
Classification
International Classes
005